Ernexa Therapeutics Inc. Warrants Stock Analysis & AI Score
Ernexa Therapeutics Inc. Warrants (ERNAW) has an ST Score of 29.0 (C-), driven by its Growth (B) and held back by its Profitability (F). ERNAW last traded at $0.04.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Ernexa Therapeutics Inc. Warrants (ERNAW) has an ST Score of 29.0 (C-), driven by its Growth (B) and held back by its Profitability (F). ERNAW last traded at $0.04.
- Strongest
- GrowthB
- Weakest
- ProfitabilityF
All factor grades
- GrowthB
- ValuationC+
- MomentumD
- Financial StrengthD-
- ProfitabilityF
Contact
ERNAW stock: frequently asked questions
What is ERNAW's ST Score?
Ernexa Therapeutics Inc. Warrants (ERNAW) has an ST Score of 29.0 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ERNAW a buy, hold, or sell?
Our ST Score grades it C- (29.0/100). The ST Score is a data-driven signal, not a recommendation.
What are ERNAW's factor grades?
Valuation C+, Profitability F, Financial Strength D-, Momentum D, Growth B.
What is ERNAW's valuation grade?
Ernexa Therapeutics Inc. Warrants (ERNAW) earns a valuation grade of C+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ERNAW's growth grade?
Ernexa Therapeutics Inc. Warrants (ERNAW) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ERNAW's profitability grade?
Ernexa Therapeutics Inc. Warrants (ERNAW) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ERNAW's financial strength grade?
Ernexa Therapeutics Inc. Warrants (ERNAW) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.